ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2017 American Transplant Congress

    Lymphoid Isolation as an Adjuvant Maneuver for Belatacept-Based Immunotherapy.

    M. Mulvihill,1 K. Samy,2 R. Davis,1 F. Leopardi,1 B. Collins,1 A. Kirk.1

    1Surgery, Duke University Medical Center, Durham, NC; 2Surgery, Indianapolis University Medical Center, Indianapolis, IN

    Purpose: Belatacept targets de novo alloimmune responses with minimal off target effects in renal transplantation, though adjuvant therapy is required for control of costimulation-blockade resistant…
  • 2017 American Transplant Congress

    Generation of Autologous CMV and EBV-Specific T-Cell Lines from Seronegative Patients for Cell Therapy of Opportunistic Infections Following Kidney Transplantation.

    C. Lamarche,1 T. Pincez,1 J. Orio,1 C. Carli,1 A. Humar,2 J.-S. Delisle.1

    1Centre de Recherche de l'Hôpital Maisonneuve-Rosemont, Montreal, QC, Canada; 2Toronto General Research Institute, Toronto, ON, Canada

    Cytomegalovirus (CMV) and Epstein-Barr virus (EBV) reactivations after kidney transplant are associated with substantial morbidity, especially in seronegative patients. Adoptive immunotherapy using virus-specific T cells…
  • 2017 American Transplant Congress

    Non-Human Primate Auto-Immune Responses to Col V, Kα-1Tubulin and Vimentin Are P2X7R Dependent.

    J. Sullivan,1 E. Jankowska-Gan,1 D. Kaufman,1 L. Denlinger,2 W. Burlingham.1

    1Surgery, University of Wisconsin, Madison, WI; 2Medicine, University of Wisconsin, Madison, WI

    Background: Auto-immune responses to Collagen type V (ColV) have been associated with coronary artery disease and lung or heart transplant rejection in humans and murine…
  • 2017 American Transplant Congress

    Increased T Cell Exhaustion in Dialysis Patients.

    M. Bastiaansen, A. Uffing, L. Riella.

    Transplantation Research Center, Brigham and Women's Hospital, Boston, MA

    Infection is a major complication post-transplantation. Evaluating the immune system prior to transplant may allow better optimization of immunosuppression dose. T cell exhaustion has been…
  • 2017 American Transplant Congress

    C1q+ and IgG3+ De Novo Donor Specific Antibody Are Associated with Allograft Failure in a Multicenter Cohort.

    C. Schinstock,1 M. Everly,2 M. Samaniego,3 M. Gandhi,1 R. Parikh,4 V. Sharma,4 M. Stegall,1 D. Dadhania.4

    1Mayo Clinic, Rochester, MN; 2Terasaki Research Institute, Los Angelos, CA; 3University of Michigan, Ann Arbor, Mi; 4Cornell University, New York, NY

    Introduction: De novo donor specific antibody (dnDSA) is a risk factor for antibody mediated rejection and allograft loss, but dnDSA does not always lead to…
  • 2017 American Transplant Congress

    Transcript Changes Associated with Graft Rejection Are Not Specific for Rejection Because They Are Shared with Tissue Responses to Wounding.

    P. Halloran, K. Famulski, INTERCOMEX Study Group.

    University of Alberta, Edmonton, Canada

    The diagnosis of rejection by histology is based on the presence of relatively non-specific lesions. This is because the histology lesions are actually non-specific, but…
  • 2017 American Transplant Congress

    Antibiotic Conservatorship in Orthotopic Liver Transplantation.

    J. Yee,2 D. Clark,2 R. Hogen,1,2 K. Dhanireddy,1 S. Biswas,2 J. Cobb,2 K. Matsushima,2 D. Grabo,2 A. Strumwasser.2

    1Solid Organ Transplantation, Keck Hospital of USC, Los Angeles, CA; 2Trauma, Acute Care Surgery, Surgical Critical Care, LAC+USC Medical Center, Los Angeles, CA

    Post-orthotopic liver transplantation (OLT) infections, especially multidrug resistant organisms (MDRO), are implicated in poorer outcomes, fueling efforts to elucidate risk factors for hospital acquired infections.…
  • 2017 American Transplant Congress

    Impact of STEEN vs Gelofusine as Perfusate During Normothermic Ex Vivo liver Perfusion on Outcome of Pig Liver Transplantation.

    I. Linares, D. Kollmann, J. Echeverri, M. Kaths, R. Rosales, C. Bruguera, M. Hamar, P. Urbanellis, S. Ganesh, N. Selzner, M. Selzner.

    Multiorgan Transplant Program, Toronto General Hospital, Toronto, ON, Canada

    European and North American clinical trials have used two different perfusate solutions for normothermic ex vivo liver perfusion (NEVLP): Gelofusine (bovine derived gelatin-based solution) and…
  • 2017 American Transplant Congress

    EPOR2/ßcR2-Independendent Effects of Low-Dose Epoetin-a in Porcine Liver Transplantation.

    L. Kebschull,1 F. Becker,1 L. Theilmann,1 B. Heitzplatz,2 W. Uennigmann,1 H. Spiegel,1 D. Palmes.1

    1Department for General and Visceral Surgery, University Hospital Münster, Münster, Germany; 2Pathology, University Hospital Münster, Münster, Germany

    Introduction: Ischemia-reperfusion injury (IRI) remains the key component of graft damage during transplantation. Mechanistically, cold-induced apoptosis, microcirculatory disturbances and radical oxygen species formation contribute to…
  • 2017 American Transplant Congress

    Healthcare Resource Utilization for Patients with Donor-Specific Antibodies Post-Kidney Transplantation.

    B. Ho,1 H. Bhagat,2 E. Lee,2,3 K. Atiemo,1 A. Daud,1 R. Kang,1 S. Montag,1,4 L. Zhao,1,4 J. Schwartz,2 D. Ladner.1

    1Northwestern University Transplant and Outcomes Research Collaborative (NUTORC), Chicago; 2Astellas Pharma Global Development, Northbrook; 3Now with UCB, Atlanta; 4Dept of Preventive Medicine, Northwestern University, Chicago

    Formation of de novo donor-specific antibodies (dnDSA) against human leukocyte antigens (HLA) contributes to inferior kidney transplant (KT) outcomes. No data exist on healthcare resource…
  • « Previous Page
  • 1
  • …
  • 61
  • 62
  • 63
  • 64
  • 65
  • …
  • 181
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences